David Arkowitz

Mr. David A. Arkowitz is an Independent Director at iBio, Inc. and a Chief Financial Officer at Alkeus Pharmaceuticals, Inc. He is on the Board of Directors at iBio, Inc. and Yumanity, Inc. Mr. Arkowitz was previously employed as an Independent Director by Kineta, Inc., a Chief Financial & Accounting Officer by Seres Therapeutics, Inc., an Independent Director by Yumanity Therapeutics, Inc., an Independent Director by F-star Therapeutics, Inc., an Independent Director by Proteostasis Therapeutics, Inc., a Chief Financial & Accounting Officer by Flexion Therapeutics, Inc., an Independent Director by F-Star Therapeutics, Inc. (United States), a Chief Operating & Financial Officer by Visterra, Inc., a Chief Financial Officer & General Manager by Mascoma Corp., a Chief Financial & Business Officer by AMAG Pharmaceuticals, Inc., a Chief Financial Officer & Treasurer by Idenix Pharmaceuticals LLC, a VP & Controller-Research & Development Division by Merck & Co., Inc., a Vice President-Finance & Business Development by Merck Frosst Canada Ltd., a Controller by Merck Research Laboratories Massachusetts LLC, and a Director-Financial Planning & Analysis by Merck-Medco Managed Care LLC.
He also served on the board at Aegerion Pharmaceuticals, Inc. and ImpactRx, Inc. He received his undergraduate degree from Brandeis University and an MBA from Columbia Business School.